Pharma Ad Portfolio
Low Dose Melatonin
Client
Carlyle (Spec)
Year
2025
Enhertu HCP
Research on why physicians aren’t using Enhertu revealed that many think that the cost of the drug may not be worth the benefit, so this campaign strives to highlight the drug as a potent tool that changes the outcomes in a significant way.
Client
AstraZeneca (Spec)
Year
2025
DSE for Long Covid
Audience: This ad is targeting patients and people who have had Covid previously- specifically Millennials and GenZ on social media. The goal is to drive awareness of how common Long Covid is, as well as amplifying engagement with the non-profit Patient-Led Research Collaborative.
Platform: This will be a mockumentary-style spot with the goal length of 2 minutes on TikTok, and a 1 minute version for IG Reels to take advantage of each algorithm’s preferred content length.
Why: Revive Therapeutics & HealthBio Therapeutics are working on treatments for Long Covid, both are in Phase III clinical trials with promising results.
What: The Big Downer (not The Grim Reaper - that’s his brother) is bored of telling everyone they have Long Covid and would like more people to go to the doctor so he can get back to breaking other kinds of bad news again.
Client
Patient-Led Research Collaborative
Year
2025